The association between type 2 diabetes mellitus and A1/A2 polymorphism of glycoprotein IIIa gene

Acta Diabetologica

Volumn 44, Issue 1, 2007, Pages 30-33

  Kozieradzka, A ^a   Kaminski K ^a   Pepinski W ^a   Janica, J ^a   Korecki, J ^a   Szepietowska, B ^a   Musial W J ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Case control study; Glycoprotein IIIa; Myocardial infarction; Polymorphism; Type 2 diabetes

Indexed keywords

GLYCOPROTEIN IIIA;

ACUTE HEART INFARCTION; ADULT; ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE METABOLISM; HETEROZYGOTE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; ST SEGMENT ELEVATION;

AGED; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; GENE FREQUENCY; HUMANS; INTEGRIN BETA3; LINKAGE (GENETICS); MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 33947219823     PISSN: 09405429     EISSN: 14325233     Source Type: Journal    
DOI: 10.1007/s00592-007-0238-6     Document Type: Article

References (11)

1. Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, Weiss JL, Gerstenblith G, Goldschmidt-Clermont PJ (1996) A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis. N Engl J Med 334:1090-1094
2. Herrmann SM, Poirier O, Marques-Vidal P, Evans A, Arveiler D, Luc G, Emmerich J, Cambien F (1997) The Leu33/Pro polymorphism (PlA1/PlA2) of the glycoprotein IIIa (GPIIIa) receptor is not related to myocardial infarction in the ECTIM Study. Etude Cas-Temoins de l'Infarctus du Myocarde. Thromb Haemost 77:1179-1181
3. Aleksic N, Juneja H, Folsom AR, Ahn C, Boerwinkle E, Chambless LE, Wu KK (2000) Platelet Pl(A2) allele and incidence of coronary heart disease: results from the Atherosclerosis Risk In Communities (ARIC) Study. Circulation 102:1901-1905
4. Bojesen SE, Juul K, Schnohr P, Tybjaerg-Hansen A, Nordestgaard BG (2003) Platelet glycoprotein IIb/IIIa Pl(A2)/Pl(A2) homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: the Copenhagen City Heart Study. J Am Coll Cardiol 42:661-667
5. Tschoepe D, Menart B, Ferber P, Altmann C, Haude M, Haastert B, Roesen P (2003) Genetic variation of the platelet-surface integrin GPIIb-IIIa (PIA1/A2-SNP) shows a high association with Type 2 diabetes mellitus. Diabetologia 46:984-989
6. Harris F, Chatfield L, Singh J, Phoenix DA (2004) Role of calpains in diabetes mellitus: a mini review. Mol Cell Biochem 261:161-167
7. Marz W, Boehm BO, Winkelmann BR, Hoffmann MM (2004) The PlA1/A2 polymorphism of platelet glycoprotein IIIa is not associated with the risk of type 2 diabetes. The Ludwigshafen Risk and Cardiovascular Health study. Diabetologia 47:1969-1973
8. Gruchała M, Ciecwierz D, Ochman K, Targonski R, Dubaniewicz W, Sobiczewski W, Wasag B, Drewla P, Skarzynski P, Romanowski P, Limon J, Rynkiewicz A (2003) Association between the PlA platelet glycoprotein GpIIIa polymorphism and extent of coronary artery disease. Int J Cardiol 88:229-237
9. Boullu-Sanchis S, Lepretre F, Hedelin G, Donnet JP, Schaffer P, Froguel P, Pinget M (1999) Type 2 diabetes mellitus: association study of five candidate genes in an Indian population of Guadeloupe, genetic contribution of FABP2 polymorphism. Diabetes Metab 25:150-156
10. Andrulionyte L, Zacharova J, Chiasson JL, Laakso M (2004) Common polymorphisms of the PPAR-gamma2 (Pro12Ala) and PGC-1alpha (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial. Diabetologia 47:2176-2184
11. Oizumi T, Daimon M, Saitoh T, Kameda W, Yamaguchi H, Ohnuma H, Igarashi M, Eguchi H, Manaka H, Tominaga M, Kato T (2001) Genotype Arg/Arg, but not Trp/Arg, of the Trp64Arg polymorphism of the beta(3)-adrenergic receptor is associated with type 2 diabetes and obesity in a large Japanese sample. Diabetes Care 24:1579-1583